736-737 / 1173
ESTRO
RT
CH
CH+RT
(EF, 40 Gy) (MOPP/ABVD)
(IF, ≤ 40 Gy)
10 y over. survival
80-90%
80-90%
≈90%
Complications (RR)
-leukemia
11.0
70.0
significantly reduced
-lymphoma
21.0
22.0
significantly reduced
-solid tumor
2.8
1.1
significantly reduced
-cardiac
2.2-3.1
≈1.0
significantly reduced
Stage I and II Hodgkin disease
(very favorable and favorable categories)